Drug intelligence / Profile preview

aifukang

Development stage
Preclinical
Administration
Oral
01

Overview

**Aifukang** is an oral multi-herb traditional Chinese medicine capsule preparation studied in China as an adjunctive treatment for HIV infection and acquired immunodeficiency syndrome. Clinical publications report improvements in patient-reported symptoms, body weight, and immunologic measures, while evidence for a direct effect on HIV viral load is inconsistent or limited. Its molecular composition, direct antiviral targets, originator, manufacturer, and regulatory marketing status were not established in the located public sources. ([ir.pku.edu.cn](https://ir.pku.edu.cn/handle/20.500.11897/231290))

Other names
Aifukang capsules艾复康艾复康胶囊

Beyond the preview

Go deeper on aifukang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aifukang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call